These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
563 related articles for article (PubMed ID: 10517426)
1. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. Hayden FG; Treanor JJ; Fritz RS; Lobo M; Betts RF; Miller M; Kinnersley N; Mills RG; Ward P; Straus SE JAMA; 1999 Oct; 282(13):1240-6. PubMed ID: 10517426 [TBL] [Abstract][Full Text] [Related]
2. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. Hayden FG; Atmar RL; Schilling M; Johnson C; Poretz D; Paar D; Huson L; Ward P; Mills RG N Engl J Med; 1999 Oct; 341(18):1336-43. PubMed ID: 10536125 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. Treanor JJ; Hayden FG; Vrooman PS; Barbarash R; Bettis R; Riff D; Singh S; Kinnersley N; Ward P; Mills RG JAMA; 2000 Feb; 283(8):1016-24. PubMed ID: 10697061 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. Hayden FG; Treanor JJ; Betts RF; Lobo M; Esinhart JD; Hussey EK JAMA; 1996 Jan 24-31; 275(4):295-9. PubMed ID: 8544269 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment. Barroso L; Treanor J; Gubareva L; Hayden FG Antivir Ther; 2005; 10(8):901-10. PubMed ID: 16430195 [TBL] [Abstract][Full Text] [Related]
6. Neuraminidase inhibitors for preventing and treating influenza in adults and children. Jefferson T; Jones MA; Doshi P; Del Mar CB; Hama R; Thompson MJ; Spencer EA; Onakpoya I; Mahtani KR; Nunan D; Howick J; Heneghan CJ Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD008965. PubMed ID: 24718923 [TBL] [Abstract][Full Text] [Related]
7. Oseltamivir: a review of its use in influenza. McClellan K; Perry CM Drugs; 2001; 61(2):263-83. PubMed ID: 11270942 [TBL] [Abstract][Full Text] [Related]
8. Neuraminidase inhibitors for preventing and treating influenza in children. Wang K; Shun-Shin M; Gill P; Perera R; Harnden A Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza--placebo-controlled double-blind multicenter phase III trial]. Kashiwagi S; Kudoh S; Watanabe A; Yoshimura I Kansenshogaku Zasshi; 2000 Dec; 74(12):1062-76. PubMed ID: 11193558 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. Welliver R; Monto AS; Carewicz O; Schatteman E; Hassman M; Hedrick J; Jackson HC; Huson L; Ward P; Oxford JS; JAMA; 2001 Feb; 285(6):748-54. PubMed ID: 11176912 [TBL] [Abstract][Full Text] [Related]
11. [Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza--placebo-controlled double-blind multicenter phase III trial]. Kashiwagi S; Kudoh S; Watanabe A; Yoshimura I Kansenshogaku Zasshi; 2000 Dec; 74(12):1044-61. PubMed ID: 11193557 [TBL] [Abstract][Full Text] [Related]
12. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Wang K; Shun-Shin M; Gill P; Perera R; Harnden A Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD002744. PubMed ID: 22513907 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial. Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590 [TBL] [Abstract][Full Text] [Related]
16. Neuraminidase inhibitors for preventing and treating influenza in children. Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. Sidwell RW; Huffman JH; Barnard DL; Bailey KW; Wong MH; Morrison A; Syndergaard T; Kim CU Antiviral Res; 1998 Feb; 37(2):107-20. PubMed ID: 9588843 [TBL] [Abstract][Full Text] [Related]
18. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Jefferson TO; Demicheli V; Di Pietrantonj C; Jones M; Rivetti D Cochrane Database Syst Rev; 2006 Jul; (3):CD001265. PubMed ID: 16855962 [TBL] [Abstract][Full Text] [Related]
19. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection. Calfee DP; Peng AW; Cass LM; Lobo M; Hayden FG Antimicrob Agents Chemother; 1999 Jul; 43(7):1616-20. PubMed ID: 10390212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]